Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
GR148672X is a triacyglycerol hydrolase (TGH) inhibitor with an IC50 of 4 nM extracted from patent WO 2001016358 A2
It serves as a useful chemical tool to further validate and develop novel treatments of osteoporosis via promoting bone formation
Smiles: C[C@H](C[C@H](N)C(O)=O)C(O)=O
2K/c1-14(2)9-21(33)47-24-23(49-51(42
PubMed PMID: 20086151
Platelet Factor 4 (58-70), human lorpheniramine maleate GR148672X is a triacyglycerol hydrolasePlatelet Factor 4 (58 70), human, a peptide based on the amino acid sequence corresponding to residues 58 70 of platelet factor 4 (PF 4), contains the major heparin binding domain, which is not sufficient for full antiangiogenic activity. Product information CAS Number: 82989 21 7 Molecular Weight: 1572. 97 Formula: C76H133N17O18 Chemical Name: (4S) 4 [(2S) 2 [(2S) 2 [(2S) 6 amino 2 [(2S) 6 amino 2 [(2S,3S) 2 [(2S,3S) 2 [(2S) 6 amino 2 [(2S) 6 amino 2
US$ 761.50
US$ 155.00
US$ 242.50
US$ 256.50
US$ 131.00
US$ 94.00
US$ 392.50